Ilya G. Berim, MD

Expert Publications

• Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it.
• Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea.
• Release of metal particles from needles used for endobronchial ultrasound-guided transbronchial needle aspiration.
• Detection of a possible case of pulmonary tumour thromboembolism by endobronchial ultrasound.
• Cellular and molecular immunology of lung cancer: therapeutic implications.
• Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis.
• Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells.
• Boerhaave Syndrome Presenting as Tension Pneumothorax: First Reported North American Case.
• Transbronchial Saline Injection to Allow Visualization and Biopsy of Peripheral Lung Nodule on Linear Endobronchial Ultrasound.

Media Releases

Get to know Pulmonologist and Critical Care Medicine Specialist Dr. Ilya G. Berim, who serves patients in New Brunswick, New Jersey.

A prominent pulmonologist and critical care medicine specialist, Dr. Berim is the Medical Director of Interventional Pulmonology at the Robert Wood Johnson University Hospital in New Brunswick, New Jersey.

Robert Wood Johnson University Hospital (RWJUH) has received national acclaim as a leading health care service, and has been recognized for outstanding clinical quality and patient safety. Their comprehensive, advanced treatments encompass everything from diabetes education and cancer treatments to heart and vascular care. Their staff is dedicated to creating a safe, comforting environment where patients and families can feel confident in the quality of their medical care.

Pertaining to his educational pursuits, Dr. Berim attended medical school at the University of Wuerzburg, Germany. After relocating to the United States, he completed his residency in internal medicine and his fellowship in pulmonary and critical care at the State University of New York at Buffalo.

An authority in his field, the doctor is board-certified in interventional pulmonology, critical care medicine, pulmonary disease, and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In 2018, after six years as an Associate Professor at CHI Omaha — Creighton University’s Department of Pulmonary and Critical Care Medicine — Dr. Berim joined Rutgers Robert Wood Johnson University Medical School as an Associate Professor of Medicine.

Pulmonology is a medical specialty that deals with diseases involving the respiratory tract. A pulmonologist is an internal medicine physician who specializes in preventing, diagnosing, and treating conditions and diseases that affect the lungs, bronchial tubes, and the respiratory system, including the nose, pharynx, and throat.

Intensive care medicine, also called critical care medicine, is a medical specialty that deals with seriously or critically ill patients who have, are at risk of, or are recovering from conditions that may be life-threatening. Critical care medicine specialists (also called intensivists) are medical doctors who specialize in the care of people who are in an intensive care unit (ICU). In some areas, when a person is very ill and has to spend time in an ICU, he or she is cared for by a critical care medicine specialist.

Speaking several languages, Dr. Berim is fluent in English, German, and Russian.

Recommended Articles

• How Pigs Are Increasing Understanding of Cystic Fibrosis

  Researchers have been trying to figure out why Cystic Fibrosis (CF) patients are unable to fight off bacterial infections.Recently, studying pigs have helped scientists understand CF better.Why pigs?Initially, mice were used to evaluate CF, but they did not spontaneously develop CF like humans do....

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• Procedure Found to Help Children with Cystic Fibrosis

  Researchers have recently found that the simple procedure of inhaling hypertonic saline solution, or HSS, can increase sputum production and improve pathogen identification in children. This breakthrough will act as a benefit to many suffering from cystic fibrosis who are unable to spontaneously...

• Pulse Oximeter Use for Patients with COPD

  Pulse oximeters measure the pulse rate of an individual, which is usually marked by a small heart. This is the first number that appears while using a pulse oximeter.  It also measures the proportion of oxygenated hemoglobin in the blood within pulsating vessels. This determines the level of oxygen...

• How to Plan for Traveling with Your Cystic Fibrosis Treatments

  Every now and then, everyone needs to take a break. In fact, taking a vacation may be just what the doctor ordered. Planning is necessary for any individual who wishes to travel; however, if you have cystic fibrosis, there are a few extra things that you need to plan for. Travel insurance, enough...

• Cystic Fibrosis Stories: Stronger Because of their Scars

  Scars are a fact of life for those suffering from Cystic Fibrosis (CF). From ports to transplants and pacemakers, most people with CF have at least one scar. Not to mention, the dark circles under their eyes from exhaustion and fatigue. Living with CF is tough; it can be draining both mentally and...